Emergent BioSolutions Ownership | Who Owns Emergent BioSolutions?


OverviewForecastRevenueFinancialsChartTranscripts

Emergent BioSolutions Ownership Summary


Emergent BioSolutions is owned by 80.01% institutional investors, 3.86% insiders, and 16.12% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.11% of EBS shares. Avantis US Small Cap Value ETF is the top mutual fund, with 4.14% of its assets in Emergent BioSolutions shares.

EBS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEmergent BioSolutions80.01%3.86%16.12%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de4.34M8.11%$36.03M
Blackrock3.84M7.36%$26.18M
Vanguard group3.55M6.68%$43.93M
State street2.85M5.33%$23.65M
Dimensional fund advisors lp2.76M5.15%$22.88M
American century companies2.43M4.53%$20.13M
Charles schwab investment management1.51M2.82%$12.50M
Acadian asset management1.38M2.58%$11.46M
Geode capital management1.27M2.38%$10.57M
Palisade capital management, lp1.20M2.25%$9.97M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Values first advisors307.88K1.33%$2.56M
Oak hill advisors lp1.11M1.05%$9.24M
Kent lake capital300.00K0.92%$2.05M
Prosight management, lp639.12K0.87%$5.30M
Prescott group capital management772.77K0.64%$6.41M
Morse asset management221.80K0.38%$1.84M
Palisade capital management, lp1.20M0.33%$9.97M
Globeflex capital l p241.30K0.30%$2.00M
Oxford asset management llp57.64K0.21%$478.39K
Palumbo wealth management80.26K0.16%$666.19K

Top Buyers

HolderShares% AssetsChange
Prosight management, lp639.12K0.87%639.12K
Aqr capital management989.68K0.00%511.65K
Dimensional fund advisors lp2.76M0.00%504.55K
Whitebox advisors500.00K0.10%500.00K
Prudential financial448.81K0.00%358.88K

Top Sellers

HolderShares% AssetsChange
Blackrock3.84M0.00%-3.22M
Oak hill advisors lp1.11M1.05%-2.50M
Avidity partners management lp---1.91M
Jain global198.98K0.01%-743.71K
Carronade capital management, lp---550.60K

New Positions

HolderShares% AssetsChangeValue
Prosight management, lp639.12K0.87%639.12K$5.30M
Whitebox advisors500.00K0.10%500.00K$3.41M
Vanguard fiduciary trust345.12K0.00%345.12K$2.86M
Kent lake capital300.00K0.92%300.00K$2.05M
Vanguard global advisers154.17K0.00%154.17K$1.28M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Flagship harbor advisors-2.00
Frazier financial advisors-2.00
Walleye capital-4.00
Federation des caisses desjardins du quebec-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026187-2.09%42,805,974-1.39%801.20%1042.97%50-3.85%
Dec 31, 202546-74.73%6,057,668-85.48%110.19%26-69.41%7-87.27%
Sep 30, 202568-61.14%10,191,249-74.33%180.35%28-72.28%19-47.22%
Jun 30, 20251723.61%39,625,9449.49%731.65%10012.36%35-12.50%
Mar 31, 20254-97.58%3,665,317-89.44%60.16%1-98.77%2-94.87%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Avantis US Small Cap Value ETF2.14M4.14%-
State Street® SPDR® S&P® Biotech ETF1.79M3.45%-17.65K
Vanguard Total Stock Mkt Idx Inv1.61M3.12%-
Vanguard US Total Market Shares ETF1.64M3.01%-
iShares Russell 2000 ETF1.23M2.39%10.39K
SPDR® S&P Biotech ETF949.18K1.78%2.12K
Schwab Fundamental U.S. Small CompanyETF879.58K1.70%6.34K
Invesco FTSE RAFI US 1500 Small-Mid ETF917.91K1.69%-
Palisade Small Cap Core Equity872.78K1.68%11.84K
Vanguard Institutional Extnd Mkt Idx Tr596.80K1.16%3.13K

Recent Insider Transactions


DateNameRoleActivityValue
May 01, 2026Dayal Sujata Tyagi-Sell$8.76K
May 01, 2026Dayal Sujata Tyagi-Sell$106.85K
May 01, 2026DeGolyer Donald W-Sell$121.45K
May 01, 2026DeGolyer Donald W-Sell$8.55K
Apr 30, 2026Katkin Keith-Sell$128.18K

Insider Transactions Trends


DateBuySell
2026 Q2-1
2026 Q1--
2025 Q4-5
2025 Q3-2
2025 Q211

EBS Ownership FAQ


Who Owns Emergent BioSolutions?

Emergent BioSolutions shareholders are primarily institutional investors at 80.01%, followed by 3.86% insiders and 16.13% retail investors. The average institutional ownership in Emergent BioSolutions's industry, Biotech Stocks , is 35.75%, which Emergent BioSolutions exceeds.

Who owns the most shares of Emergent BioSolutions?

Emergent BioSolutions’s largest shareholders are Blackrock funding, inc. /de (4.34M shares, 8.11%), Blackrock (3.84M shares, 7.36%), and Vanguard group (3.55M shares, 6.68%). Together, they hold 22.15% of Emergent BioSolutions’s total shares outstanding.

Does Blackrock own Emergent BioSolutions?

Yes, BlackRock owns 7.36% of Emergent BioSolutions, totaling 3.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.18M$. In the last quarter, BlackRock decreased its holdings by -3.221M shares, a -45.62% change.

Who is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested?

Values first advisors is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested, with 1.33% of its assets in 307.88K Emergent BioSolutions shares, valued at 2.56M$.

Who is the top mutual fund holder of Emergent BioSolutions shares?

Avantis US Small Cap Value ETF is the top mutual fund holder of Emergent BioSolutions shares, with 4.14% of its total shares outstanding invested in 2.14M Emergent BioSolutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools